Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CKAP2L antibody (AA 200-250)

This Rabbit Polyclonal antibody specifically detects CKAP2L in IP. It exhibits reactivity toward Human.
Catalog No. ABIN7452238

Quick Overview for CKAP2L antibody (AA 200-250) (ABIN7452238)

Target

CKAP2L (Cytoskeleton Associated Protein 2-Like (CKAP2L))

Reactivity

Human

Host

  • 7
Rabbit

Clonality

  • 7
Polyclonal

Conjugate

  • 3
  • 2
  • 1
  • 1
This CKAP2L antibody is un-conjugated

Application

  • 5
  • 1
  • 1
  • 1
  • 1
Immunoprecipitation (IP)
  • Binding Specificity

    • 5
    • 1
    AA 200-250

    Purpose

    Rabbit anti-CKAP2L Antibody, Affinity Purified

    Purification

    Affinity Purified

    Immunogen

    between AA 200 and 250

    Isotype

    IgG
  • Application Notes

    IP: 2 - 5 μg/mg lysate

    WB: Not recommended. ABIN7452238 has not performed satisfactorily when used for WB of CKAP2L in crude preparations (e.g. whole cell lysate). This antibody can be used for WB of enriched (e.g. immunoprecipitated) sources of CKAP2L.

    Restrictions

    For Research Use only
  • Concentration

    1000 μg/mL

    Buffer

    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Expiry Date

    12 months
  • Target

    CKAP2L (Cytoskeleton Associated Protein 2-Like (CKAP2L))

    Alternative Name

    CKAP2L

    Background

    Background: CKAP2L (cytoskeleton-associated protein 2-like) has been identified in a mass-spectrometry-based search for phosphorylation sites in mitotic spindle-associated proteins. In similar mass-spectometry based experiments, it has also been identified as a protein whose phosphorylation is cell cycle regulated.

    Gene ID

    150468

    NCBI Accession

    NP_689728

    UniProt

    Q8IYA6
You are here:
Chat with us!